Gene: MCRIP1
Official Full Name: MAPK regulated corepressor interacting protein 1provided by HGNC
Gene Summary: Involved in regulation of epithelial to mesenchymal transition. Located in cytoplasmic stress granule and nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO04795 | MCRIP1 Knockout cell line (HeLa) | Human | MCRIP1 | 1:3~1:6 | Negative | Online Inquiry |
KO04796 | MCRIP1 Knockout cell line (HCT 116) | Human | MCRIP1 | 1:2~1:4 | Negative | Online Inquiry |
KO04797 | MCRIP1 Knockout cell line (HEK293) | Human | MCRIP1 | 1:3~1:6 | Negative | Online Inquiry |
KO04798 | MCRIP1 Knockout cell line (A549) | Human | MCRIP1 | 1:3~1:4 | Negative | Online Inquiry |
MCRIP1 Gene Knockout Cell Lines are specialized cellular models designed to facilitate in-depth studies of the MCRIP1 gene's function by effectively knocking out its expression. These cell lines utilize advanced CRISPR/Cas9 gene-editing technology to create specific genetic alterations that serve as valuable tools for examining the biological pathways and processes in which MCRIP1 is involved. By eliminating the gene’s activity, researchers can probe into the effects and compensatory mechanisms that arise from MCRIP1 knockout, providing a clearer understanding of its role in cellular functions and disease etiology.
The key mechanism underlying these cell lines hinges on targeted genome editing, enabling precise modifications at the genomic level. This technique ensures a high rate of successful gene disruption, thereby minimizing off-target effects and maximizing research reliability. The MCRIP1 gene is often studied in connection with various biological processes, including cell signaling and metabolic pathways, making its knockout an essential technique for elucidating complex interactions within cellular networks.
In research and clinical settings, MCRIP1 Gene Knockout Cell Lines hold significant scientific importance as they can provide insights into the gene's involvement in various pathologies, including cancer and metabolic diseases. The ability to simulate a knockout state allows researchers to identify potential therapeutic targets and to discover novel pharmacological agents.
What sets our MCRIP1 Gene Knockout Cell Lines apart from alternatives is their meticulous validation and characterization, ensuring robust and reproducible results. Our commitment to quality means that each batch undergoes rigorous testing to confirm effective gene disruption and cellular integrity, providing confidence in experimental outcomes.
For researchers and clinicians seeking reliable and precise cellular models, these knockout cell lines represent a unique and indispensable resource, delivering cutting-edge solutions to advance biological research and therapeutic development. Our company specializes in providing high-quality biological products, backed by extensive expertise in gene editing technologies, ensuring that you receive the most advanced tools for your scientific inquiries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.